Cryptic HBV Replicative Activity Is Frequently Revealed in Anti-HBc-Positive/HBsAg-Negative Patients with HIV Infection by Highly Sensitive Molecular Assays, and Can Be Predicted by Integrating Classical and Novel Serological HBV Markers

The anti-HBc-positive/HBsAg-negative status is frequent in HIV-infection and correlates with poor survival. Here, by highly-sensitive assays, we evaluate cryptic HBV replication and factors correlated with its detection in 81 anti-HBc-positive/HBsAg-negative HIV-infected patients. Patients were trea...

Full description

Bibliographic Details
Published in:	Microorganisms
Main Authors:	Romina Salpini, Vincenzo Malagnino, Lorenzo Piermatteo, Tiziana Mulas, Mohammad Alkhatib, Rossana Scutari, Elisabetta Teti, Carlotta Cerva, Katia Yu La Rosa, Marta Brugneti, Ada Bertoli, Benedetta Rossi, Vera Holzmayer, Jeffrey Gersch, Mary Kuhns, Gavin Cloherty, Francesca Ceccherini-Silberstein, Carlo-Federico Perno, Marco Iannetta, Massimo Andreoni, Loredana Sarmati, Valentina Svicher
Format:	Article
Language:	English
Published:	MDPI AG 2020-11-01
Subjects:	HBV HIV anti-HBc titer anti-HBs titer serum HBV-DNA serum HBV-RNA
Online Access:	https://www.mdpi.com/2076-2607/8/11/1819

Similar Items

Highly Sensitive HBsAg, Anti-HBc and Anti HBsAg Titres in Early Diagnosis of HBV Reactivation in Anti-HBc-Positive Onco-Haematological Patients
by: Carlotta Cerva, et al.
Published: (2022-02-01)

Association between Elevated TGA-IgA Titers and Older Age at Diagnosis with Absence of HBV Seroconversion in Celiac Children
by: Chiara Maria Trovato, et al.
Published: (2021-01-01)

HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV Reactivation
by: Lorenzo Piermatteo, et al.
Published: (2021-09-01)

Hepatitis B Surface Antibody (Anti-HBs) Kinetics during Rituximab Chemotherapy and Performance of Hepatitis B Vaccine before Immunosuppression: Two Prospective Studies
by: João Marcello de Araujo-Neto, et al.
Published: (2022-08-01)

Clinical Significance and Remaining Issues of Anti-HBc Antibody and HBV Core-Related Antigen
by: Yoshihiko Yano, et al.
Published: (2024-03-01)

Kinetics of hepatitis B virus replication in anti-HBc positive/HBsAg-negative people with HIV switching to tenofovir sparing therapy
by: Romina Salpini, et al.
Published: (2025-01-01)

HBV vaccination of HCV-infected patients with occult HBV infection and anti-HBc-positive blood donors
by: J.S.F. Pereira, et al.
Published: (2006-04-01)

Editorial: HBV and lymphoma
by: Giuseppe Gentile, et al.
Published: (2023-07-01)

THE USE OF DRIED BLOOD SPOTS FOR MEASURING THE IMMUNITY AGAINST HBV
by: Chijdem Ismailova, et al.
Published: (2019-06-01)

Following-up the long-term efficacy of hepatitis B vaccine in immunization of risky occupational groups
by: Meside Gunduzoz, et al.
Published: (2020-06-01)

Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies
by: Lorenzo Piermatteo, et al.
Published: (2023-12-01)

Anti-HBc IgG Responses Occurring at the Early Phase of Infection Correlate Negatively with HBV Replication in a Mouse Model
by: Xuyang Wang, et al.
Published: (2022-09-01)

Mechanisms underlying the compromised clinical efficacy of interferon in clearing HBV
by: Zhuoyan Lei, et al.
Published: (2024-12-01)

Anti-HDV seroprevalance among patients with previous HBV infection
by: Abdurrahman Sahin, et al.
Published: (2018-06-01)

Serological prevalence of hepatitis B virus (HBV) in Mardan district, Khyber Pakhtunkhwa, Pakistan
by: N. Ullah, et al.
Published: (2021-07-01)

Çocuklarda HBV Aşısının Koruyuculuk Oranı ve Anti-HBs Değerlerinin Yaş ve Cinsiyet İle Olan İlişkisi
by: Hayrullah Yazar, et al.
Published: (2012-09-01)

The Culprit Behind HBV-Infected Hepatocytes: NTCP
by: Li S, et al.
Published: (2024-10-01)

Persistent Hepatitis B Viraemia with Polymerase Mutations among HIV/HBV Co-Infected Patients on HBV-Active ART in KwaZulu-Natal, South Africa
by: Nokukhanya Msomi, et al.
Published: (2022-04-01)

The dose of HBV genome contained plasmid has a great impact on HBV persistence in hydrodynamic injection mouse model
by: Lei Li, et al.
Published: (2017-10-01)

HBV genotypes and antiviral therapy of hepatitis B
by: I.A. Zaitsev, et al.
Published: (2019-09-01)

Implementation of Guideline-Based HBV Reactivation Management in Patients with Chronic HBV Infections of HBsAg or Resolved HBV Infection Undergoing Immunosuppressive Therapy
by: Yasuhito Tanaka, et al.
Published: (2024-05-01)

Persistence of Anti-HB Antibodies in Healthcare Trainees: The Impact of Childhood Versus Adolescent Vaccination
by: Luca Di Giampaolo, et al.
Published: (2025-05-01)

PREVALENCE OF ANTI-HBC IN HBSAG-NEGATIVE POPULATION
by: Daniel Ivanov, et al.
Published: (2020-05-01)

Is there Emergence of Clinical HBV Resistance Under Long-Term HBV Combination Therapy? A Challenging Case Report
by: Jürgen Kurt Rockstroh, et al.
Published: (2010-07-01)

Analysis of Hepatitis B virus (HBV) mutations in patients from Western Saudi Arabia with chronic disease
by: Sherif Aly El-Kafrawy, et al.
Published: (2018-07-01)

HCC-derived SNU cell lines as model systems to study HBV life cycle
by: Igor Zaiets, et al.
Published: (2025-10-01)

HBV-RNA, Quantitative HBsAg, Levels of HBV in Peripheral Lymphocytes and HBV Mutation Profiles in Chronic Hepatitis B
by: Yael Gozlan, et al.
Published: (2022-03-01)

Analysis of HBV infection characteristics and OBI prevalence in pregnant women: a focus on HBcAb + alone or in combination with HBeAb + subgroups in Northwest China
by: Yun Xie, et al.
Published: (2025-08-01)

The progress of molecules and strategies for the treatment of HBV infection
by: Youlu Pan, et al.
Published: (2023-03-01)

Liver transplantation for HBV-related liver disease: Impact of prophylaxis for HBV on HCC recurrence
by: Patrizia Burra, et al.
Published: (2025-03-01)

The Role of Antiviral Prophylaxis in Preventing HBV and HDV Recurrence in the Setting of Liver Transplantation
by: Sara Battistella, et al.
Published: (2023-04-01)

HBcAb Positivity as a Risk Factor for Missing HIV RNA Undetectability after the 3TC+DTG Switch
by: Vincenzo Malagnino, et al.
Published: (2024-02-01)

Hepatitis B Virus (HBV) Reactivation Following Pharmacological Eradication of Hepatitis C Virus (HCV)
by: Mariantonietta Pisaturo, et al.
Published: (2019-09-01)

Coexisting patterns and significance of serum HBV RNA and HBV DNA in patients with treatment-naïve chronic hepatitis B virus infection
by: Kun-yan Hao, et al.
Published: (2025-01-01)

Investigation of HBV DNA in HBsAg positive patients
by: Nihal Secil Bati, et al.
Published: (2017-12-01)

Role of HBcAb Positivity in Increase of HIV-RNA Detectability after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Months 48 Results of a Multicenter Italian Cohort
by: Vincenzo Malagnino, et al.
Published: (2023-01-01)

Multicenter Evaluation of the Cepheid Xpert<sup>®</sup> HBV Viral Load Test
by: Fabbio Marcuccilli, et al.
Published: (2021-02-01)

In situ analysis of hepatitis B virus (HBV) antigen and DNA in HBV-induced hepatocellular carcinoma
by: Ye Zheng, et al.
Published: (2022-01-01)

Na<sup>+</sup>-Taurocholate Co-Transporting Polypeptide (NTCP) in Livers, Function, Expression Regulation, and Potential in Hepatitis B Treatment
by: Xiaoyu Zhao, et al.
Published: (2021-11-01)

Effect of SARS-CoV-2 infection on HBV-infected patients: Reactivation
by: Laith A I K Al-Kaif, et al.
Published: (2022-01-01)